Rollout of the Aidence Veye Chest AI

Lung cancer remains the deadliest cancer in France, with a 5-year survival rate of just 15%; yet detection at stage 1 raises that figure to 80%.

Carrying out lung cancer screening therefore opens up a major avenue for prevention.

Building on the first (2D) AI tools already deployed (Gleamer and qRX), we are pleased to announce the addition to our portal of the Aidence Veye Chest module for detecting pulmonary nodules (CT), in collaboration with Incepto.

Veye Chest (CE-marked) streamlines the radiologist’s workflow by detecting, classifying and tracking the growth of pulmonary nodules.

Contact us

Want to join us? Please select the category that applies to you and attach your documents (specifications, CV/resume, and/or specific requests) so that your message can be processed promptly. You can also contact us at: email@telediag.com

Contact us

Want to join us? Please select the category that applies to you and attach your documents (specifications, CV/resume, and/or specific requests) so that your message can be processed promptly. You can also contact us at: email@telediag.com

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.